CNCR vs. BIB ETF Comparison

Comparison of Loncar Cancer Immunotherapy ETF (CNCR) to ProShares Ultra Nasdaq Biotechnology (BIB)
CNCR

Loncar Cancer Immunotherapy ETF

CNCR Description

ETF Series Solutions - Loncar Cancer Immunotherapy ETF is an exchange traded fund launched by ETF Series Solutions. The fund is co-managed by Exchange Traded Concepts, LLC and Vident Investment Advisory, LLC. It invests in public equity markets of the United States. The fund invests in stocks of companies operating in the pharmaceutical or biotechnology sectors, including those companies identified as having a high strategic focus on the development of drugs that harness the body's own immune system to fight cancer. It invests in stocks of companies across all market capitalizations. The fund seeks to replicate the performance of the Loncar Cancer Immunotherapy Index, by investing in stocks of companies as per their weightings in the index. ETF Series Solutions - Loncar Cancer Immunotherapy ETF is domiciled in the United States.

Grade (RS Rating)

Last Trade

$15.43

Average Daily Volume

44,891

Number of Holdings *

71

* may have additional holdings in another (foreign) market
BIB

ProShares Ultra Nasdaq Biotechnology

BIB Description The investment seeks daily investment results that correspond to two times (2x) the daily performance of the Nasdaq Biotechnology Index®. The fund invests in securities and derivatives that ProShare Advisors believes, in combination, should have similar daily return characteristics as two times (2x) the daily return of the index. The index is a modified capitalization weighted index that includes securities of NASDAQ listed companies that are classified as either biotechnology or pharmaceutical according to the Industry Classification Benchmark ("ICB") which also meet other eligibility criteria determined by NASDAQ. The fund is non-diversified.

Grade (RS Rating)

Last Trade

$53.74

Average Daily Volume

35,958

Number of Holdings *

204

* may have additional holdings in another (foreign) market
Performance
Period CNCR BIB
30 Days -1.91% -1.14%
60 Days -13.51% -10.53%
90 Days 5.56% -5.75%
12 Months 17.25% -3.45%
45 Overlapping Holdings
Symbol Grade Weight in CNCR Weight in BIB Overlap
ACLX C 1.07% 0.22% 0.22%
ALLO F 0.95% 0.04% 0.04%
ARVN D 1.02% 0.18% 0.18%
AUTL F 1.04% 0.05% 0.05%
BCYC B 1.39% 0.07% 0.07%
BMEA F 0.9% 0.03% 0.03%
BNTX C 1.33% 0.69% 0.69%
BPMC A 1.48% 0.45% 0.45%
CGEM A 1.57% 0.07% 0.07%
CRBU F 1.01% 0.03% 0.03%
DAWN A 1.5% 0.11% 0.11%
DCPH A 1.29% 0.1% 0.1%
ELVN B 2.13% 0.06% 0.06%
ERAS D 1.27% 0.02% 0.02%
EXEL B 1.47% 0.58% 0.58%
GERN A 2.87% 0.16% 0.16%
GMAB F 1.32% 0.1% 0.1%
HCM A 1.54% 0.05% 0.05%
IDYA C 1.25% 0.24% 0.24%
IMCR D 1.37% 0.16% 0.16%
INBX D 1.38% 0.13% 0.13%
IOVA C 1.16% 0.26% 0.26%
ITOS B 1.38% 0.03% 0.03%
JANX A 1.79% 0.2% 0.2%
KURA C 1.2% 0.11% 0.11%
KYMR C 1.25% 0.17% 0.17%
LEGN D 0.96% 0.29% 0.29%
LYEL B 1.46% 0.05% 0.05%
MGNX D 1.37% 0.08% 0.08%
MRUS B 1.32% 0.2% 0.2%
NRIX D 1.37% 0.05% 0.05%
NUVL C 1.12% 0.32% 0.32%
PGEN C 1.39% 0.03% 0.03%
RAPT F 1.32% 0.02% 0.02%
REGN C 1.33% 5.92% 1.33%
REPL F 1.01% 0.03% 0.03%
RLAY F 1.09% 0.07% 0.07%
RVMD A 1.56% 0.47% 0.47%
RXRX F 1.03% 0.15% 0.15%
SMMT B 1.06% 0.2% 0.2%
SNDX C 1.29% 0.14% 0.14%
SWTX D 1.23% 0.26% 0.26%
XNCR B 1.21% 0.09% 0.09%
YMAB B 1.43% 0.05% 0.05%
ZNTL F 1.17% 0.07% 0.07%
CNCR Overweight 26 Positions Relative to BIB
Symbol Grade Weight
ACRV B 2.63%
NUVB B 1.7%
TSVT D 1.51%
MRK B 1.48%
MOR C 1.41%
IPHA F 1.36%
AURA D 1.34%
VOR F 1.32%
BMY F 1.31%
SDGR F 1.31%
ACET F 1.28%
TYRA B 1.27%
GLUE D 1.26%
PRLD D 1.22%
FHTX D 1.21%
STRO D 1.21%
IMTX C 1.19%
RCUS D 1.18%
KPTI F 1.14%
DNA F 1.12%
IGMS D 1.1%
RPTX F 0.89%
FATE D 0.83%
MRSN D 0.81%
GNLX F 0.78%
IMRX F 0.73%
CNCR Underweight 159 Positions Relative to BIB
Symbol Grade Weight
AMGN B -6.29%
VRTX C -6.01%
GILD F -5.87%
MRNA A -3.35%
AZN A -3.34%
BIIB D -2.36%
ILMN D -1.57%
ALNY D -1.46%
BMRN F -1.38%
NBIX A -1.11%
VTRS C -1.1%
SNY B -1.03%
RPRX C -1.01%
MEDP D -0.99%
INCY D -0.94%
SRPT B -0.94%
ARGX C -0.94%
UTHR A -0.9%
ASND C -0.66%
ITCI B -0.57%
CYTK D -0.55%
JAZZ F -0.54%
PCVX C -0.53%
IONS D -0.5%
BGNE D -0.48%
APLS F -0.48%
HALO C -0.4%
CRSP D -0.36%
KRYS C -0.36%
BBIO D -0.35%
IMVT D -0.34%
ALPN A -0.34%
MDGL D -0.33%
ALKS F -0.33%
INSM D -0.31%
RARE D -0.29%
FTRE C -0.27%
AXSM D -0.27%
FOLD D -0.25%
XENE C -0.24%
CRNX A -0.24%
ARWR D -0.23%
ACAD F -0.22%
RYTM C -0.19%
GH D -0.18%
VCEL B -0.18%
VERA B -0.17%
RCKT D -0.17%
DNLI F -0.17%
PTCT B -0.16%
AMPH D -0.16%
RNA A -0.16%
KROS C -0.16%
DYN C -0.16%
NTLA F -0.16%
BEAM F -0.15%
SANA B -0.15%
TWST C -0.14%
AGIO A -0.14%
SUPN C -0.13%
HRMY B -0.13%
MYGN C -0.13%
ADMA A -0.12%
DVAX D -0.12%
VCYT D -0.12%
ARDX D -0.12%
PTGX D -0.12%
EWTX B -0.12%
FUSN A -0.12%
NVCR F -0.11%
ANIP B -0.11%
MORF F -0.11%
PCRX D -0.1%
FDMT C -0.1%
LGND C -0.1%
IRWD F -0.1%
VIR F -0.09%
PRTA F -0.09%
MIRM D -0.09%
TARS B -0.09%
MNKD C -0.09%
COLL B -0.09%
AKRO F -0.09%
ABCL F -0.09%
INVA A -0.08%
MRVI B -0.08%
SRRK C -0.08%
VRNA D -0.08%
ALXO A -0.07%
SAGE F -0.07%
ARQT D -0.07%
BCRX F -0.07%
RGNX D -0.06%
KNSA B -0.06%
PLRX F -0.06%
ARCT F -0.06%
AUPH F -0.06%
ZLAB F -0.06%
GRFS F -0.06%
SPRY B -0.06%
ETNB F -0.06%
EYPT D -0.06%
OLMA D -0.05%
CVAC F -0.05%
GLPG F -0.05%
SVRA C -0.05%
NVAX F -0.05%
WVE B -0.05%
SIGA A -0.05%
EOLS C -0.05%
IRON F -0.05%
COGT D -0.05%
EDIT F -0.04%
URGN D -0.04%
TSHA D -0.04%
FULC D -0.04%
TBPH B -0.04%
THRD A -0.04%
ABUS D -0.04%
MLYS C -0.04%
PETQ D -0.04%
ALEC D -0.04%
OCUL D -0.04%
ANAB B -0.04%
PHAT D -0.04%
OABI D -0.04%
CNTA C -0.04%
ORIC D -0.04%
CSTL B -0.04%
PRME F -0.04%
VERV F -0.04%
CABA F -0.04%
ATAI B -0.03%
RVNC F -0.03%
AMRN D -0.03%
HROW F -0.03%
PACB F -0.03%
ADPT F -0.03%
LXRX D -0.03%
HUMA B -0.03%
VYGR D -0.03%
TVTX F -0.03%
KALV B -0.03%
QURE F -0.02%
OVID F -0.02%
CHRS F -0.02%
ACIU F -0.02%
XERS D -0.02%
VTYX F -0.02%
PAHC A -0.02%
VNDA B -0.02%
AVXL F -0.02%
TERN F -0.02%
MGTX D -0.02%
MRNS F -0.01%
ACRS C -0.01%
ME D -0.01%
BLUE F -0.01%
RPHM C -0.0%
Compare ETFs